Cumhur Tekin

3PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 01, 2025
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.

Yong-Man Kim, Shin Nishio, Se Ik Kim

|Nov 05, 2024
Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.

Bradley J Monk, Sophie van Mens, Oliver Hale

|Jun 10, 2024
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.

Min-Hyun Baek, Lei Chen, Cumhur Tekin

Pageof 1

Frequent Collaborators

2 joint publications

Bradley J Monk

1 joint publications

Min-Hyun Baek

1 joint publications

Lei Chen

1 joint publications

Razvan Cristescu